Microbot Medical Inc. (MBOT) Earnings History
Net Loss35 years of earnings data (1991–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Microbot Medical Inc. (MBOT) Earnings Overview
As of June 22, 2026, Microbot Medical Inc. (MBOT) reported trailing twelve-month net income of -$14M, reflecting +60.3% year-over-year growth. The company earned $-0.21 per diluted share over the past four quarters.
Looking at the long-term picture, MBOT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2001.
Microbot Medical Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SSYS (-$115M net income, -18.9% margin), RBOT (-$42M net income), TRVI (-$46M net income), MBOT has comparable earnings metrics. Compare MBOT vs SSYS →
MBOT Earnings vs Peers
Earnings metrics vs comparable public companies
MBOT Historical Earnings Data (1991–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$13M | -14.8% | -$15M | $-0.29 | - | - |
| 2024 | -$11M | -6.5% | -$12M | $-0.73 | - | - |
| 2023 | -$11M | +18.4% | -$10M | $-1.05 | - | - |
| 2022 | -$13M | -16.4% | -$13M | $-1.81 | - | - |
| 2021 | -$11M | -23.4% | -$11M | $-1.59 | - | - |
| 2020 | -$9M | -26.5% | -$9M | $-1.29 | - | - |
| 2019 | -$7M | +0.2% | -$7M | $-1.70 | - | - |
| 2018 | -$7M | +4.3% | -$7M | $-0.81 | - | - |
| 2017 | -$8M | +21.5% | -$5M | $-0.85 | - | - |
| 2016 | -$10M | +73.5% | -$10M | $-10.14 | - | - |
| 2015 | -$36M | -11.2% | -$37M | $-7.20 | -31123.9% | -31384.6% |
| 2014 | -$33M | -23.8% | -$31M | $-858.60 | -3235.3% | -3054.3% |
| 2013 | -$26M | +7.2% | $-805 | $-986.43 | -2197.8% | -0.1% |
| 2012 | -$28M | -33.6% | -$22M | $-1603.80 | -2082.7% | -1622.0% |
| 2011 | -$21M | +15.5% | -$27M | $-2430.00 | -1746.8% | -2222.3% |
| 2010 | -$25M | +6.6% | -$29M | $-3321.00 | -1769.0% | -2041.9% |
| 2009 | -$27M | +7.1% | $29M | $-4050.00 | -2722.0% | 2958.9% |
| 2008 | -$29M | -16.2% | $27M | $-5670.00 | -12552.1% | 11538.4% |
| 2007 | -$25M | -32.1% | $29M | $-5022.00 | -44115.2% | 50405.5% |
| 2006 | -$19M | -61.4% | $21M | $-4050.00 | -20407.1% | 23016.7% |
| 2005 | -$12M | +23.4% | -$14M | $-2916.00 | -5700.4% | -6585.8% |
| 2004 | -$15M | -24.7% | -$13M | $-5022.00 | -10869.7% | -8914.9% |
| 2003 | -$12M | -18.6% | $12M | $-7290.00 | -4495.1% | 4442.1% |
| 2002 | -$10M | -200.8% | $10M | $-7452.00 | -2495.3% | 2458.0% |
| 2001 | -$3M | +69.6% | $12M | $-4050.00 | -428.0% | 1438.8% |
| 2000 | -$11M | +27.8% | $9M | $-9396.00 | -15263.8% | 12471.1% |
| 1999 | -$16M | -24.7% | -$10M | $-13608.00 | -312.8% | -196.9% |
| 1998 | -$13M | +30.4% | $14M | $-11178.00 | -143.1% | 153.4% |
| 1997 | -$18M | -31.2% | -$14M | $-17496.00 | -170.8% | -134.0% |
| 1996 | -$14M | -55.1% | $16M | $-14418.00 | -194.4% | 221.1% |
| 1995 | -$9M | +46.1% | $8M | $-11178.00 | -75.4% | 63.6% |
| 1994 | -$17M | -32.0% | $17M | $-24624.00 | -1269.2% | 1300.0% |
| 1993 | -$13M | -25.0% | $12M | $-23814.00 | -416.7% | 406.7% |
| 1992 | -$10M | -56.3% | $10M | $-20703.93 | -714.3% | 692.9% |
| 1991 | -$6M | - | $6M | $-16452.44 | -1280.0% | 1280.0% |
Download Data
Export MBOT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
35+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MBOT — Frequently Asked Questions
Quick answers to the most common questions about buying MBOT stock.
What is MBOT earnings per share (EPS)?
MBOT trailing twelve-month (TTM) diluted EPS is $-0.21, reflecting +60.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1991 to 2025 is available in the table on this page.
What is Microbot Medical Inc.'s net income?
Microbot Medical Inc. (MBOT) trailing twelve-month net income is $-14M as of 2025. Earnings grew +60.3% year-over-year.
Is MBOT profitable?
MBOT is not currently profitable on a TTM basis, reporting a net loss of $-14M. Net margin is N/A. Investors should monitor for a return to profitability.
What is MBOT's earnings growth rate?
MBOT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1991 to 2025.
What are MBOT's profit margins?
Microbot Medical Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -32.4%.
Is MBOT growing earnings?
Yes, MBOT earnings are accelerating — EPS growth of +60.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-14M. Earnings momentum is strengthening.
What was MBOT's best earnings year?
Microbot Medical Inc.'s highest annual net income on record is $-3M, achieved in fiscal year 2001. Earnings history on this page spans 1991 to 2025 and includes all annual and quarterly figures.
What were MBOT's earnings last quarter?
MBOT's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.